Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair

Gynecologic Oncology

Volumn 108, Issue 2, 2008, Pages 438-444

  Case, Ashley S ^a   Zighelboim, Israel ^a   Mutch, David G ^a   Babb, Sheri A ^a   Schmidt, Amy P ^a   Whelan, Alison J ^a   Thibodeau, Stephen N ^b   Goodfellow, Paul J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mayo Clinic   (United States)

Author keywords

DNA mismatch repair; Endometrial cancer; HNPCC; Lynch syndrome

Indexed keywords

DNA; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; COLON CARCINOMA; DNA DETERMINATION; DNA POLYMORPHISM; FAMILIAL CANCER; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC LINKAGE; GENOTYPE; GYNECOLOGIC CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHYLATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA METHYLATION; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LINKAGE (GENETICS); MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PEDIGREE; PROMOTER REGIONS (GENETICS);

EID: 38649142449     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.09.036     Document Type: Article

References (25)

1. Chen S., Wang W., Lee S., Nafa K., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 12 (2006) 1479-1487
2. Valle L., Perea J., Carbonell P., Fernandez V., Dotor A., et al. Clinicopathologic and pedigree differences in Amsterdam-I positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25 7 (2007) 1-6
3. Vasen H.F., Mecklin J.P., Khan P.M., and Lynch H.T. The International Collaborative Group on hereditary non-polyposis colorectal cancer. Dis Colon Rectum 34 5 (1991) 424-425
4. Vasen H.F.A., Watson P., Mecklin J.P., and Lynch H.P. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116 (1999) 1453-1456
5. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., et al. A National Cancer Institute Workshop on hereditary non-polyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89 (1997) 1758-1761
6. Boland C.R. Evolution for the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 4 (2005) 211-218
7. Hampel H., Frankel W., Panescu J., Lockman J., et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66 15 (2006) 7810-7817
8. Lindor N.M., Peterson G.M., Hadley D.W., Kinney A.Y., Miesfelt S., et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296 12 (2006) 1507-1517
9. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6 1 (1997) 105-110
10. Peiffer S.L., Herzog T.J., Tribune D.J., Mutch D.G., Gersell D.J., and Goodfellow P.J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55 (1995) 1922-1926
11. + endometrial cancers. Genes Chromosomes Cancer 18 (1997) 219-227
12. Thibodeau S.N., French A.J., Cunningham J.M., Tester D., Burgart L.J., et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58 8 (1998) 1713-1718
13. Chen H., Taylor N.P., Sotamaa K.M., Mutch D.G., Powell M.A., et al. Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer 120 8 (2007) 1684-1688
14. Whelan A., Babb S., Mutch D., Rader J., Herzog T., Todd C., et al. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Int J Cancer 99 (2002) 697-704
15. Simpkins S.B., Bocker T., Swisher E.M., Mutch D.M., et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancer. Hum Mol Genet 8 4 (1999) 661-666
16. Marsit C.J., Houseman E.A., Christensen B.C., Eddy K., Bueno R., et al. Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res 66 21 (2006) 10621-10629
17. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., and Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
18. Whitcomb B.P., Mutch D.G., Herzog T.J., Rader J.S., et al. Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res 9 6 (2003) 2277-2287
19. Lagerstedt Robinson K., Liu T., Vandrovcova J., Halvarsson B., et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 99 4 (2007) 291-299
20. Llor X., Pons E., Xicola R., Castells A., Alenda C., et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11 20 (2005) 7304-7310
21. Jass Jr., Cottier D.S., Jeevarantam P., et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 346 (1995) 1200-1201
22. Lindor N.M., Rabe K., Peterson G.M., Haile R., Casey G., Baron J., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293 16 (2005) 1979-1985
23. Lindor N.M., Petersen G.M., Hadley D.W., Kinney A.Y., et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296 12 (2007) 1507-1517
24. Schmeler K.M., Lynch H.T., Chen L.M., et al. Prophylactic surgery to reduce the risk of gynecologic cancers in Lynch syndrome. N Engl J Med 354 (2006) 261-269
25. Suter C.M., Martin D.I., and Ward R.L. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36 (2004) 497-501